Literature DB >> 10440856

Use of a mechanical dissociation device to improve standardization of flow cytometric cytokeratin DNA measurements of colon carcinomas.

G Brockhoff1, S Fleischmann, A Meier, F P Wachs, F Hofstaedter, R Knuechel.   

Abstract

In order to standardize dual-fluorescence DNA flow cytometry using cytokeratin (CK) antibodies, normal colonic mucosa and tumor tissue were sampled from 308 colorectal surgical specimens. Fresh colon specimens were processed directly and stored frozen until dissociation. The samples were divided into aliquots for manual dissociation with tweezers and scalpel, and parallel dissociation with an automated disaggregation device (Medimachine, DAKO Diagnostika GmbH, Hamburg, Germany). An indirect immunofluorescence method with anti-cytokeratin antibodies and propidiumiodide was applied and measured on a single-laser flow cytometer (FACScan, Becton Dickinson [BDI], Heidelberg, Germany). Evaluation with CellFit (BDI) or MultiPlus (Phoenix Flow Systems, San Diego, CA) showed that dual-parameter fluorescence propidiumiodide (DNA staining) and fluorescein-isothiocyanate (cytokeratin labeling) provides a reasonable staining method for DNA analysis of epithelial cells. No significant differences in coefficient of variation in CK-gated versus ungated cells could be observed. Normal colon mucosa served as a reliable internal, diploid DNA control. Medimachine dissociation led to a significantly higher gain of cytokeratin-positive cells compared to percentage of cytokeratin-positive cells after manual tissue disaggregation. Cytokeratin gating led to a clear-cut separation of S-phase fractions within the respective ploidy groups, irrespective of manual or automated dissociation. The S-phase fraction increased significantly from normal tissue to diploid and nondiploid tumors. In general, automated tissue preparation with the Medimachine allows simple cell-isolation for dual DNA/CK-flow cytometric measurement, improving the gain of CK-positive cells, and facilitating a standardized DNA analysis. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10440856     DOI: 10.1002/(sici)1097-0320(19990815)38:4<184::aid-cyto5>3.0.co;2-w

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  6 in total

Review 1.  Optimal molecular profiling of tissue and tissue components: defining the best processing and microdissection methods for biomedical applications.

Authors:  G Steven Bova; Isam A Eltoum; John A Kiernan; Gene P Siegal; Andra R Frost; Carolyn J M Best; John W Gillespie; Gloria H Su; Michael R Emmert-Buck
Journal:  Mol Biotechnol       Date:  2005-02       Impact factor: 2.695

2.  Predominance of activated, clonally expanded T helper type 17 cells within the CD4+ T cell population in psoriatic lesions.

Authors:  B J Lewis; S Rajpara; A M Haggart; H M Wilson; R N Barker; A D Ormerod
Journal:  Clin Exp Immunol       Date:  2013-07       Impact factor: 4.330

3.  Dissociation of skeletal muscle for flow cytometric characterization of immune cells in macaques.

Authors:  Frank Liang; Aurélie Ploquin; Karin Loré; Nancy J Sullivan; José DelaO Hernández; Hugues Fausther-Bovendo; Gustaf Lindgren; Daphne Stanley; Aiala Salvador Martinez; Jason M Brenchley; Richard A Koup
Journal:  J Immunol Methods       Date:  2015-06-20       Impact factor: 2.303

4.  Automated-Mechanical Procedure Compared to Gentle Enzymatic Tissue Dissociation in Cell Function Studies.

Authors:  Mariele Montanari; Sabrina Burattini; Caterina Ciacci; Patrizia Ambrogini; Silvia Carloni; Walter Balduini; Daniele Lopez; Giovanna Panza; Stefano Papa; Barbara Canonico
Journal:  Biomolecules       Date:  2022-05-14

5.  Single Cell Gene Expression Analysis in a 3D Microtissue Liver Model Reveals Cell Type-Specific Responses to Pro-Fibrotic TGF-β1 Stimulation.

Authors:  Catherine Jane Messner; Lmar Babrak; Gaia Titolo; Michaela Caj; Enkelejda Miho; Laura Suter-Dick
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

6.  In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs.

Authors:  D M Ashley; C D Riffkin; M M Lovric; T Mikeska; A Dobrovic; J A Maxwell; H S Friedman; K J Drummond; A H Kaye; H K Gan; T G Johns; C J Hawkins
Journal:  Br J Cancer       Date:  2008-07-01       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.